Both obesity and T2D are associated with increased risk for some common cancers and potential biological mechanisms (including the insulin/insulin‐like growth factor axis, hyperglycemia, chronic inflammation, sex hormones, and an altered microbiome) may also underlie the relationship between MASLD and EHC.14, 15. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.